Can You Take Cyclosporine and Simvastatin Together?

No. According to U.S. FDA drug labeling, cyclosporine and simvastatin should not be used together. The combination is contraindicated—meaning it is not recommended under any standard circumstance—because it significantly increases your risk of myopathy (muscle disease) and rhabdomyolysis (a serious breakdown of muscle tissue that can cause kidney failure). If you are currently taking both medications, you should not stop either one on your own; instead, contact your pharmacist or physician immediately to discuss your options.

What the Source Says

The interaction between cyclosporine and simvastatin is classified as contraindicated, the most serious category of drug interaction. According to labeling sourced from NLP analysis of simvastatin prescribing information, concomitant use of these two medications is not recommended because it increases the risk of myopathy and rhabdomyolysis.

This guidance comes directly from FDA-regulated drug labeling for simvastatin, one of the primary sources used by checkdruginteractions.com. The source record does not specify the underlying mechanism of this interaction, but the documented clinical risk is clear: the two drugs together pose a hazard that outweighs any benefit of using them in combination.

The contraindicated classification means this is not an interaction to monitor or manage with adjusted doses or closer follow-up. It is a combination that standard medical practice recommends against entirely.

How to Understand This

To make sense of this recommendation, it helps to understand what each drug does and why their combination is problematic.

Cyclosporine is an immunosuppressant medication used to prevent organ rejection after transplantation and to treat certain autoimmune conditions. It works by slowing down your immune system so that it does not attack a transplanted organ or attack your own body in autoimmune disease.

Simvastatin is a statin—a class of medications used to lower cholesterol and reduce the risk of heart disease. Statins work by blocking an enzyme in your liver that produces cholesterol.

Both cyclosporine and simvastatin are metabolized (broken down) in the body by the liver, and both can accumulate to higher-than-intended levels under certain conditions. Myopathy—muscle pain, weakness, or damage—and rhabdomyolysis (severe muscle breakdown) are known adverse effects associated with statins, particularly when they reach high concentrations in the bloodstream.

The source record supplied by FDA labeling does not specify the exact mechanism by which cyclosporine increases this myopathy risk when combined with simvastatin. However, the documented clinical observation is strong enough that prescribers and pharmacists are advised not to use these medications together. This reflects a body of clinical experience and safety monitoring indicating that the risk is real and significant.

It is important to note: this is not an interaction where monitoring, dose adjustment, or timing changes make the combination safe. The recommendation is to avoid the pairing altogether.

Who Should Pay Particular Attention

If you have had an organ transplant, you are very likely taking cyclosporine or a related immunosuppressant. If you also have high cholesterol or are at risk for heart disease, you might reasonably expect to take a statin. This situation creates a clinical dilemma: you may need cholesterol management, but simvastatin specifically is not an option.

Similarly, if you are being treated with cyclosporine for an autoimmune condition and your physician has prescribed simvastatin for cholesterol, this combination should be flagged for review.

Anyone who has been prescribed both medications should prioritize discussing alternatives with a pharmacist or physician. Other statins (such as pravastatin or rosuvastatin) may be safer alternatives, or your doctor may recommend a different approach to cholesterol management entirely, depending on your clinical situation.

A Hypothetical Example

Imagine you received a kidney transplant five years ago and have been taking cyclosporine successfully to prevent rejection. Your latest blood work shows that your cholesterol is elevated, and your physician wants to start you on a statin to reduce your risk of heart disease. If your physician prescribes simvastatin without checking your current medication list, you (or your pharmacist) should flag this immediately. Simvastatin is contraindicated with cyclosporine, so a different statin or a different cholesterol-management strategy would need to be chosen instead. This is not a case where "a little extra monitoring" makes the combination acceptable; the interaction record explicitly recommends against concomitant use.

What to Discuss With a Pharmacist or Physician

If you are taking cyclosporine and simvastatin, or if you have been prescribed one and are considering the other, bring this up with your healthcare team right away. Here are some questions and points to raise:

• "I am taking both cyclosporine and simvastatin. I have learned that this combination is contraindicated. What should I do?" Do not wait for your next routine visit; contact your prescriber or pharmacist promptly.
• "Are there alternative statins or other cholesterol-management options I can use safely with cyclosporine?" Pravastatin and rosuvastatin are examples of other statins; your doctor will know which alternatives are appropriate for your medical history.
• "If I must continue cyclosporine and need cholesterol treatment, what is the safest approach?" Your physician may recommend a non-statin cholesterol medication, lifestyle changes, or a different statin with a lower interaction risk.
• "How do I know if I am having muscle problems from this interaction?" Ask your doctor about symptoms to watch for, such as unexplained muscle pain, weakness, or dark urine (which can indicate muscle breakdown).
• "If I stop simvastatin, how soon should I expect changes in my cholesterol?" Your doctor can advise on the timeline for restoring cholesterol control with a safer alternative.

Do not stop either medication on your own. Even though simvastatin is contraindicated with cyclosporine, abruptly stopping either drug can create other medical problems. Work with your healthcare team to transition safely.

Key Takeaways

• Cyclosporine and simvastatin are contraindicated — FDA-regulated drug labeling advises against using them together because the combination increases the risk of myopathy and rhabdomyolysis.
• The documented risk is serious enough that this is not an interaction to manage with dose adjustment or monitoring; the two drugs should be separated.
• If you are taking both medications, contact your pharmacist or physician immediately to discuss alternatives.
• Other statins or non-statin cholesterol treatments may be safer options if you must take cyclosporine.
• Never stop either medication on your own; work with your healthcare team to transition safely to a safer combination.

Sources

• FDA Open—U.S. Food and Drug Administration Drug Information
• DailyMed—NLM/NIH Drug Labeling Database
• RxNorm—NLM Drug Name and Classification Database
• PubMed—National Library of Medicine Literature Search

This information is based on FDA-regulated drug labeling sourced through the National Library of Medicine and analyzed by checkdruginteractions.com. It is intended to help you understand documented drug interactions and communicate more effectively with your healthcare providers. It is not a substitute for professional medical advice. Always confirm medication decisions—including whether to start, stop, or change a drug—with a pharmacist or physician who knows your full medical history. To check for interactions between all of your medications, visit checkdruginteractions.com and review your complete medication list with a healthcare provider today.